Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.
Transl Lung Cancer Res.

Qiu B, Cai K, Chen C, Chen J, Chen KN, Chen QX, Cheng C, Dai TY, Fan J, Fan Z, Hu J, Hu WD, Huang YC, Jiang GN, Jiang J, Jiang T, Jiao WJ, Li HC, Li Q, Liao YD, Liu HX, Liu JF, Liu L, Liu Y, Long H, Luo QQ, Ma HT, Mao NQ, Pan XJ, Tan F, Tan LJ, Tian H, Wang D, Wang WX, Wei L, Wu N, Wu QC, Xiang J, Xu SD, Yang L, Zhang H, Zhang L, Zhang P, Zhang Y, Zhang Z, Zhu K, Zhu Y, Um SW, Oh IJ, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Sasada S, Uchino J, Sugimura H, Dermime S, Cappuzzo F, Rizzo S, Cho WC, Crucitti P, Longo F, Lee KY, De Ruysscher D, Vanneste BGL, Furqan M, Sieren JC, Yendamuri S, Merrell KW, Molina JR, Metro G, Califano R, Bongiolatti S, Provencio M, Hofman P, Gao S, He J.

2021 Sep;10(9):3713-3736.

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas.
Diagnostics (Basel)

Mograbi B, Heeke S, Hofman P.
 

2021 Jan 29;11(2):196

To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.
Purinergic Signal

Janho Dit Hreich S, Benzaquen J, Hofman P, Vouret-Craviari V.

2021 Dec;17(4):619-631.

Using Genetics To Dissect SARS-CoV-2 Infection.
Trends Genet.

Brest P, Mograbi B, Hofman P, Milano G.

2021 Mar;37(3):203-204.

Orbital exenteration: an updated review with perspectives.
Surv Ophthalmol.

Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Lassalle S, Lagier J, Hamedani M, Poissonnet G.

2021 Sep-Oct;66(5):856-876.

PD-L1 regulation revisited: impact on immunotherapeutic strategies.
Trends Mol Med.

Lucibello G, Mograbi B, Milano G, Hofman P, Brest P.
 

2021 Sep;27(9):868-881.

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.
Cell Death Differ

Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C.
 

2021 Jun;28(6):1990-2000.

Histopathological features due to the SARS-CoV-2
Ann. Pathol.

2021 Feb; 41(1): 9–22

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.
Nat Commun

2021 Jan 28;12(1):653

Morphologic and molecular classification of lung neuroendocrine neoplasms.
Virchows Arch.

Metovic J, Barella M, Bianchi F, Hofman P, Hofman V, Remmelink M, Kern I, Carvalho L, Pattini L, Sonzogni A, Veronesi G, Harari S, Forest F, Papotti M, Pelosi G.

2021 Jan;478(1):5-19.

Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry. Nature Medicine

Hofman P, Puchois P, Brest P, Lahlou H, Simeon-Dubach D.

2020 May 7

Open Questions for Harnessing Autophagy-Modulating Drugs in the SARS-CoV-2 War. Preprints.

Brest P, Benzaquen J, J.Klionsky D, Hofman P, Mograbi B.

2020 April 3 ;1 : 0022

Practical use of biobank information management system (BIMS) for clinical-biological annotations in biobanks. Med Sci (Paris).

Le Queau C, Phillips W, Srinivasan A.

2020 March 31;36(3) : 285-288.

Biobankonomics: the sustainability indicators of biobanks. Med Sci (Paris).

Sqalli H, El Awadi N, Rancati C.

2020 March 31;36(3) : 282-285.

Bioethique. Legal and ethical considerations for the use of biobanks. Med Sci (Paris).

Messaoudi Z, Soltani N, Arrighi N.

2020 March 31;36(3) : 279-282.

Impact of the pre-analytical phase on the quality of samples collected in biobanks. Med.Sci (Paris).

Amalfitano M, Dong Q, Keita A.

2020 March 31;36(3) : 277-279.

Introduction into the world of biobanks in human health. Med Sci (Paris).

Liney T, Mitov A, Gbago Onivogui L, Arrighi N.

2020 March 31;36(3) : 274-276.

Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? Ann Oncol.

Hofman P, Heeke S, Alix-Panabières C, Pantel K.
 

2019 Sep 1;30(9):1448-1459.